FIELD: medicine.
SUBSTANCE: invention is related to the field of medicine, in particular pharmacy, and is related to new antitumor agent, which represents biligand complex of vanadyl with malic acid - bis(L-malato)oxovanadium (IV).
EFFECT: agent is described that displays antitumor activity.
2 ex, 7 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
OXOVANADIUM COMPLEXES OF L-MALIC ACID SHOWING HYPOGLYCEMIC ACTIVITY | 1996 |
|
RU2101287C1 |
BIOLOGICALLY ACTIVE NUTRITIVE SUPPLEMENT WITH INSULIN-LIKE EFFECT BASED ON BIS-(L-MALATO)-OXOVANADIUM (IV) | 2000 |
|
RU2191018C2 |
OXOVANADIUM COMPLEX WITH GLYCINE MANIFESTING HYPOGLYCEMIC ACTIVITY | 2007 |
|
RU2341528C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIDIABETIC EFFECT BASED ON OXOVANADIUM DERIVATIVE AND METHOD FOR IT PREPARING | 2001 |
|
RU2203656C1 |
NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
OXOVANADIUM (IV) COMPLEX IN DIMETHYL SULPHOXIDE POSSESSING ANTIDIABETIC ACTION AND METHOD FOR PRODUCING IT | 2014 |
|
RU2559894C1 |
METHOD OF MELIOIDOZE ANTIGEN ESTIMATE FOR PROTECTIVITY LEVEL | 2007 |
|
RU2354400C1 |
SODIUM COBALT POLYGALACTURONATE WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2794885C1 |
APPLICATION OF TRIINDOLYL METHANE DERIVATIVES AS ANTICANCER DRUGS | 2010 |
|
RU2454232C2 |
APTAMER CYTOTOXICITY ESTIMATION METHOD | 2018 |
|
RU2696849C1 |
Authors
Dates
2009-12-20—Published
2008-03-26—Filed